Takeda Pharmaceutical Co ADR (NYSE:TAK) shares, rose in value on Thursday, November 21, with the stock price up by 0.30% to the previous day’s close as strong demand from buyers drove the stock to $13.33.
Actively observing the price movement in the last trading, the stock closed the session at $13.29, falling within a range of $13.245 and $13.35. The value of beta (5-year monthly) was 0.464 whereas the PE ratio was 22.11 over 12-month period. Referring to stock’s 52-week performance, its high was $15.08, and the low was $12.57. On the whole, TAK has fluctuated by -3.82% over the past month.
With the market capitalization of Takeda Pharmaceutical Co ADR currently standing at about $42.26 billion, investors are eagerly awaiting this quarter’s results, scheduled for in December. The company’s Forward Dividend Ratio is 0.29, with its dividend yield at 2.19%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 4.43T, with a low estimate of 1.06T and a high estimate of 1.13T. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.1T.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TAK’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0.66, with the price of TAK currently trading nearly -2.78% and -5.67% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 34.17, while the 7-day volatility ratio is showing 1.14% which for the 30-day chart, stands at 1.13%. Furthermore, Takeda Pharmaceutical Co ADR (TAK)’s beta value is 0.55, and its average true range (ATR) is 0.18.
A comparison of Takeda Pharmaceutical Co ADR (TAK) with its peers suggests the former has fared considerably weaker in the market. TAK showed an intraday change of 0.30% in last session, and over the past year, it shrunk by -4.92%%.
Data on historical trading for Takeda Pharmaceutical Co ADR (NYSE:TAK) indicates that the trading volumes over the past 10 days have averaged 1.99 and over the past 3 months, they’ve averaged 1.73 million. According to company’s latest data on outstanding shares, there are 3.17 billion shares outstanding.
Nearly 0.02% of Takeda Pharmaceutical Co ADR’s shares belong to company insiders and institutional investors own 5.17% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.03 million shares as on 2024-10-31, resulting in a short ratio of 3.61. According to the data, the short interest in Takeda Pharmaceutical Co ADR (TAK) stood at 19.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 8.42 million. The stock has fallen by -6.59% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TAK stock heading into the next quarter.
